NDAINJECTIONINJECTABLE
Approved
Feb 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM CITRATE GA 67 (gallium citrate ga-67) by Curium Pharma is clinical pharmacology gallium citrate ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. First approved in 1979.
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Citrate GA-67 is a radioactive diagnostic imaging agent that concentrates in viable tumors and focal infection sites, enabling detection and localization. The mechanism involves accumulation in cellular lysosomes and binding to intracellular proteins, with highest initial tissue concentration in the renal cortex before shifting to bone, lymph nodes, liver, and spleen. It is administered by intravenous injection for oncologic and infectious disease imaging.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), indicating a contracted or stable team focused on market defense rather than expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Gallium Citrate Ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. The mechanism of concentration is unknown, but investigational studies have shown that gallium Ga-67 accumulates in…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium Citrate GA-67 offers limited career growth or mobility opportunities, as the product is in a mature, LOE-approaching lifecycle with no linked job openings and no active development pipeline. Career progression is best suited to professionals seeking stability in manufacturing, compliance, and operational roles rather than commercial expansion or innovation.
Worked on GALLIUM CITRATE GA 67 at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.